Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Proietto

Showing results (51-60 of 107) with videos related to

Pageof 11
Sort By:
Diabetes|July 1, 1987
Role of the oropharynx in regulation of glycemiaJ Proietto, F Rohner-Jeanrenaud, E Ionescu, et al.
Diabetes|December 1, 1986
Mechanism of abnormal oral glucose tolerance of genetically obese fa/fa ratsF Rohner-Jeanrenaud, J Proietto, E Ionescu, et al.
Diabetologia|October 1, 1983
Glucose utilization in Type 1 (insulin-dependent) diabetes: Evidence for a defect not reversible by acute elevations of insulinJ Proietto, A Nankervis, P Aitken, et al.
Diabetologia|April 27, 2013
A novel mechanism regulating insulin secretion involving Herpud1 in miceN Wong, G Morahan, M Stathopoulos, et al.
Clinical Endocrinology|December 1, 1984
Hyperinsulinaemia and insulin resistance of cirrhosis: the importance of insulin hypersecretionJ Proietto, F J Dudley, P Aitken, et al.
Metabolism: Clinical and Experimental|December 1, 1982
Insulin action and cirrhosis: insulin binding and lipogenesis in isolated adipocytesM S Harewood, J Proietto, F Dudley, et al.
Regulatory Peptides|November 5, 1998
Reduced BAT function as a mechanism for obesity in the hypophagic, neuropeptide Y deficient monosodium glutamate-treated ratM J Morris, C F Tortelli, A Filippis, et al.
Diabetes Research and Clinical Practice|March 1, 1994
Effects of dexfenfluramine on glucose turnover in non-insulin-dependent diabetes mellitusJ Proietto, A W Thorburn, S Fabris, et al.
Diabetologia|October 1, 1982
Differential effects of insulin therapy on hepatic and peripheral insulin sensitivity in Type 2 (non-insulin-dependent) diabetesA Nankervis, J Proietto, P Aitken, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 24, 2007
Leptin in the pathophysiology of human obesity and the clinical potential of leptin-based therapyA W Thorburn, D A Ainslie, B Fam, et al.
Pageof 11

Showing results (51-60 of 107) with videos related to

Sort By:
Pageof 11
Diabetes|July 1, 1987
Role of the oropharynx in regulation of glycemiaJ Proietto, F Rohner-Jeanrenaud, E Ionescu, et al.
Diabetes|December 1, 1986
Mechanism of abnormal oral glucose tolerance of genetically obese fa/fa ratsF Rohner-Jeanrenaud, J Proietto, E Ionescu, et al.
Diabetologia|October 1, 1983
Glucose utilization in Type 1 (insulin-dependent) diabetes: Evidence for a defect not reversible by acute elevations of insulinJ Proietto, A Nankervis, P Aitken, et al.
Diabetologia|April 27, 2013
A novel mechanism regulating insulin secretion involving Herpud1 in miceN Wong, G Morahan, M Stathopoulos, et al.
Clinical Endocrinology|December 1, 1984
Hyperinsulinaemia and insulin resistance of cirrhosis: the importance of insulin hypersecretionJ Proietto, F J Dudley, P Aitken, et al.
Metabolism: Clinical and Experimental|December 1, 1982
Insulin action and cirrhosis: insulin binding and lipogenesis in isolated adipocytesM S Harewood, J Proietto, F Dudley, et al.
Regulatory Peptides|November 5, 1998
Reduced BAT function as a mechanism for obesity in the hypophagic, neuropeptide Y deficient monosodium glutamate-treated ratM J Morris, C F Tortelli, A Filippis, et al.
Diabetes Research and Clinical Practice|March 1, 1994
Effects of dexfenfluramine on glucose turnover in non-insulin-dependent diabetes mellitusJ Proietto, A W Thorburn, S Fabris, et al.
Diabetologia|October 1, 1982
Differential effects of insulin therapy on hepatic and peripheral insulin sensitivity in Type 2 (non-insulin-dependent) diabetesA Nankervis, J Proietto, P Aitken, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 24, 2007
Leptin in the pathophysiology of human obesity and the clinical potential of leptin-based therapyA W Thorburn, D A Ainslie, B Fam, et al.
Pageof 11